Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Welsh Assembly Government Written Statement - National Social Services Conference 2009, Wales
Title:

Planned Improvements Will Reduce Mixed Sex Accommodation Throughout Somerset's Community Hospitals, England
Hospital facilities upgrades due for completion by June 2009. Measures to reduce and eventually eliminate mixed sex wards and washing facilities throughout Somerset"s 13 community hospitals are nearing completion. Last year the government pledged to reduce mixed sex accommodation throughout all England"s NHS hospitals. All hospitals have now stepped up their efforts to deliver this goal.
News of the day
Top Six Summer Dangers: ER Doctor Offers Tips For Keeping Kids Safe
As the temperatures rise, so do trips to pediatric emergency rooms. Severe cuts, broken bones and head injuries are the most common causes for trips to the emergency room during the summer, says Tony Scalzo, M.D., professor of pediatric emergency medicine at Saint Louis University School of Medicine.
Diagnostics

High-Grade Prostate Cancer Outcomes Treated With Combination Of Brachytherapy, External Beam Radiotherapy And Hormonal Therapy

UroToday.com - In the online edition of the BJU International, Dr. Richard Stock and colleagues from Mt. Sinai School of Medicine in New York reported on their outcomes using combined radiotherapy approach to men with high-risk prostate cancer (CaP). The study cohort include 181 men with Gleason score 8-10 CaP treated with androgen deprivation therapy (ADT), brachytherapy, and external beam radiotherapy (ERBT) in combination between 1994 and 2006. The study is non-randomized, single institution and retrospective. The ADT was for 3 months followed by brachytherapy and then 2 months later concomitant ADT and ERBT were delivered. The total ADT duration was 9 months. 103Pd was the isotope for all brachytherapy and most men received a dose of 100Gy with 45Gy ERBT. Median follow-up was 65 months and the Phoenix definition of PSA recurrence was used. The overall 8-year actuarial freedom from biochemical failure was 73%. In 36 patients with a biochemical relapse, the median time to PSA failure was 33 months with 53% failing within 3 years. The median PSADT was 2.7 months. Metastatic CaP developed in 22 patients and the 8-year freedom from distant metastases rate was 80%. The cancer-specific survival and overall survival at 8 years were 87% and 79%, respectively. In men experiencing PSA relapse, the 8-year CSS and overall survival were 53% and 51%, respectively. In multivariable analysis, only Gleason score and initial PSA significantly affected the development of biochemical failure. Toxicity from this treatment approach was not reported. Stock RG, Cesaretti JA, Hall SJ, Stone NN BJU Int. 2009 Jun 2. Epub ahead of print. doi:10.1111/j.1464-410X.2009.08661.x Written by UroToday.com Contributing Editor Christopher P. Evans, MD, FACS UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice. To access the latest urology news releases from UroToday, go to: www.urotoday.com Copyright © 2009 - UroToday Copyright: Medical News Today Not to be reproduced without permission of Medical News Today


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009